Telum Therapeutics is a biotechnology company leveraging proprietary metagenomic datasets, synthetic biology and generative AI to develop novel antimicrobial therapies. The company is dedicated to developing innovative antimicrobial therapies for the treatment of severe multidrug-resistant bacterial infections. Its proprietary APEX platform enables the discovery and development of novel biologically derived, protein-based antimicrobial candidates targeting clinically important Gram-negative and Gram-positive pathogens.